Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study

BACKGROUND: Recent studies indicate that survivin (BIRC5) is sensitive to the existence of previous ischemic heart disease, since it is activated in the process of tissue repair and angiogenesis. The aim of this study was to determine the potential of survivin (BIRC5) as a new cardiac biomarker in t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Biochem
Main Authors: Marković, Danica, Jevtović-Stoimenov, Tatjana, Ćosić, Vladan, Stošić, Biljana, Dinić, Vesna, Marković-Živković, Bojana, Janković, Radmilo J.
Formato: Artigo
Idioma:Inglês
Publicado em: Sciendo 2018
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6294091/
https://ncbi.nlm.nih.gov/pubmed/30581346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jomb-2017-0046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados